I-Strides Pharma Science Limited (i-Strides) namhlanje ibhengeze ukuba i-subsidiary yayo ephantsi ngokupheleleyo, i-Strides Pharma Global Pte. I-Limited, Singapore, ifumene imvume ye-Tetracycline Hydrochloride Capsules USP, 250 mg kunye ne-500 mg evela kwi-United States Food & Drug Administration (USFDA). Imveliso yinguqulelo eqhelekileyo ye-Achromycin V Capsules, 250 mg kunye ne-500 mg, ye-Avet Pharmaceuticals Inc (yangaphambili i-Heritage Pharmaceuticals Inc.)Ngokwedatha ye-IQVIA MAT, imakethi yase-US yeTetracycline Hydrochloride Capsules USP, 250 mg imalunga ne-50 mg US$ 16 yezigidi. Imveliso iya kuveliswa kwiziko le-flagship yenkampani e-Bangalore kwaye iya kuthengiswa ngu-Strides Pharma Inc. kwimarike yase-US. Inkampani ine-123 cumulative ANDA filings kunye ne-USFDA apho i-84 ANDAs ivunyiwe kwaye i-39 ilindele ukuvunywa.Tetracycline Hydrochloride I-Capsule sisibulala-ntsholongwane esisetyenziselwa ukunyanga izifo ezininzi ezahlukeneyo zebhaktiriya zolusu, amathumbu, umgudu wokuphefumla, umchamo. iphecana, amalungu angasese, i-lymph nodes, kunye nezinye iinkqubo zomzimba. Kwezinye iimeko, i-tetracycline Hydrochloride Capsule isetyenziswa xa i-penicillin okanye enye i-antibiotic ingasetyenziselwa ukunyanga izifo ezinzulu ezifana ne-Anthrax, i-Listeria, i-Clostridium, i-Actinomyces. ukuvalwa kwangaphambili kwe-Rs. 437. Inani elipheleleyo lezabelo ezithengiswe ngexesha lemini yi-146733 kwiintengiso ezingaphezu kwe-5002. Isitokhwe sabetha i-intraday ephezulu ye-Rs. 473.4 kunye ne-intraday low ye-440. Intsalela yemali emini yayiyi-Rs. 66754491.